Stay updated on Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Results data for primary and secondary outcomes with time points are now displayed. Updated study completion dates and the list of participating sites are also reflected.
    Difference
    0.4%
    Check dated 2025-11-03T21:06:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T05:36:40.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Page update includes a new version tag (v3.1.0) and removal of several MedlinePlus topics and an older version tag (v3.0.2).
    Difference
    0.4%
    Check dated 2025-09-29T03:07:32.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. No changes to core content, pricing, stock availability, or time slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T19:26:19.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T16:12:36.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and location in St. Louis, Missouri, as well as the introduction of topics related to drug safety and counterfeit drugs. Notably, the previous version's references to various drug classifications and mental health disorders have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:00:46.000Z thumbnail image

Stay in the know with updates to Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.